Patents by Inventor Roxanne L. Richman

Roxanne L. Richman has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 6645202
    Abstract: A control system alters one or more characteristics of an ablating element to ablate tissue. In one aspect, the control system delivers energy nearer to the surface of the tissue by changing the frequency or power. In another aspect, the ablating element delivers focused ultrasound which is focused in at least one dimension. The ablating device may also have a number of ablating elements with different characteristics such as focal length.
    Type: Grant
    Filed: October 27, 2000
    Date of Patent: November 11, 2003
    Assignee: Epicor Medical, Inc.
    Inventors: Benjamin Pless, Scott C. Anderson, Jonathan L. Podmore, Matthias Vaska, John E. Crowe, Roxanne L. Richman, Timothy Ciciarelli, David A. Gallup, Jack E. Ulstad, Jr.
  • Publication number: 20030079753
    Abstract: The invention provides apparatus and methods for mapping conduction pathways and creating lesions in the heart wall for the treatment of atrial fibrillation. The apparatus may include at least one epicardial ablation probe having a plurality of electrodes for creating a lesion. The apparatus and method facilitate the formation of a lesion which electrically isolates the pulmonary veins from the surrounding myocardium.
    Type: Application
    Filed: August 30, 2002
    Publication date: May 1, 2003
    Applicant: EPICOR, INC.
    Inventors: Matthias Vaska, Benjamin Pless, David A. Gallup, Jack E. Ulstad, Scott C. Anderson, Roxanne L. Richman
  • Publication number: 20030069574
    Abstract: An ablating device has a cover which holds an interface material such as a gel. The cover contains the interface material during initial placement of the device. The ablating device may also have a removable tip or a membrane filled with fluid. In still another aspect, the ablating device may be submerged in liquid during operation.
    Type: Application
    Filed: December 5, 2001
    Publication date: April 10, 2003
    Applicant: Epicor, Inc.
    Inventors: John W. Sliwa, Matthias Vaska, Jonathan L. Podmore, Roxanne L. Richman, Scott C. Anderson, Gerard Champsaur, John E. Crowe
  • Publication number: 20030069577
    Abstract: The invention provides apparatus and methods for mapping conduction pathways and creating lesions in the heart wall for the treatment of atrial fibrillation. The apparatus may include at least one epicardial ablation probe having a plurality of electrodes for creating a lesion. The apparatus and method facilitate the formation of a lesion which electrically isolates the pulmonary veins from the surrounding myocardium.
    Type: Application
    Filed: August 30, 2002
    Publication date: April 10, 2003
    Applicant: EPICOR, INC.
    Inventors: Matthias Vaska, Benjamin Pless, David A. Gallup, Jack E. Ulstad, Scott C. Anderson, Roxanne L. Richman
  • Publication number: 20030028187
    Abstract: The invention provides apparatus and methods for mapping conduction pathways and creating lesions in the heart wall for the treatment of atrial fibrillation. The apparatus may include at least one epicardial ablation probe having a plurality of electrodes for creating a lesion. The apparatus and method facilitate the formation of a lesion which electrically isolates the pulmonary veins from the surrounding myocardium.
    Type: Application
    Filed: June 12, 2002
    Publication date: February 6, 2003
    Applicant: Epicor, Inc.
    Inventors: Matthias Vaska, Benjamin Pless, David A. Gallup, Jack E. Ulstad, Scott C. Anderson, Roxanne L. Richman
  • Patent number: 6484727
    Abstract: The invention provides apparatus and methods for mapping conduction pathways and creating lesions in the heart wall for the treatment of atrial fibrillation. The apparatus may include at least one epicardial ablation probe having a plurality of electrodes for creating a lesion. The apparatus and method facilitate the formation of a lesion which electrically isolates the pulmonary veins from the surrounding myocardium.
    Type: Grant
    Filed: November 15, 1999
    Date of Patent: November 26, 2002
    Assignee: Epicor, Inc.
    Inventors: Matthias Vaska, Banjamin Pless, David A. Gallup, Jack E. Ulstad, Jr., Scott C. Anderson, Roxanne L. Richman
  • Patent number: 6474340
    Abstract: The invention provides apparatus and methods for mapping conduction pathways and creating lesions in the heart wall for the treatment of atrial fibrillation. The apparatus may include at least one epicardial ablation probe having a plurality of electrodes for creating a lesion. The apparatus and method facilitate the formation of a lesion which electrically isolates the pulmonary veins from the surrounding myocardium.
    Type: Grant
    Filed: November 15, 1999
    Date of Patent: November 5, 2002
    Assignee: Epicor, Inc.
    Inventors: Matthias Vaska, Benjamin Pless, David A. Gallup, Jack E. Ulstad, Jr., Scott C. Anderson, Roxanne L. Richman
  • Publication number: 20020128639
    Abstract: A control system alters one or more characteristics of an ablating element to ablate tissue. In one aspect, the control system delivers energy nearer to the surface of the tissue by changing the frequency or power. In another aspect, the ablating element delivers focused ultrasound which is focused in at least one dimension. The ablating device may also have a number of ablating elements with different characteristics such as focal length.
    Type: Application
    Filed: December 21, 2001
    Publication date: September 12, 2002
    Applicant: EPICOR, INC., a Delaware Corporation
    Inventors: Benjamin Pless, Scott C. Anderson, Jonathan L. Podmore, Matthias Vaska, John E. Crowe, Roxanne L. Richman, Timothy Ciciarelli, David A. Gallup, Jack E. Ulstad
  • Publication number: 20020087157
    Abstract: An ablating device has a cover which holds an interface material such as a gel. The cover contains the interface material during initial placement of the device. The ablating device may also have a removable tip or a membrane filled with fluid. In still another aspect, the ablating device may be submerged in liquid during operation.
    Type: Application
    Filed: December 5, 2001
    Publication date: July 4, 2002
    Applicant: Epicor, Inc.
    Inventors: John W. Sliwa, Matthias Vaska, Jonathan L. Podmore, Roxanne L. Richman, Scott C. Anderson, Gerard Champsaur, John E. Crowe
  • Publication number: 20020072741
    Abstract: An ablating device has a cover which holds an interface material such as a gel. The cover contains the interface material during initial placement of the device. The ablating device may also have a removable tip or a membrane filled with fluid. In still another aspect, the ablating device may be submerged in liquid during operation.
    Type: Application
    Filed: June 19, 2001
    Publication date: June 13, 2002
    Inventors: John W. Sliwa, Matthias Vaska, Jonathan L. Podmore, Roxanne L. Richman, Scott C. Anderson, Gerard Champsaur, John E. Crowe
  • Publication number: 20020045895
    Abstract: An ablating device has a cover which holds an interface material such as a gel. The cover contains the interface material during initial placement of the device. The ablating device may also have a removable tip or a membrane filled with fluid. In still another aspect, the ablating device may be submerged in liquid during operation.
    Type: Application
    Filed: December 5, 2001
    Publication date: April 18, 2002
    Applicant: Epicor, Inc.
    Inventors: John W. Sliwa, Matthias Vaska, Jonathan L. Podmore, Roxanne L. Richman, Scott C. Anderson, Gerard Champsaur, John E. Crowe
  • Publication number: 20020042611
    Abstract: An ablating device has a cover which holds an interface material such as a gel. The cover contains the interface material during initial placement of the device. The ablating device may also have a removable tip or a membrane filled with fluid. In still another aspect, the ablating device may be submerged in liquid during operation.
    Type: Application
    Filed: December 5, 2001
    Publication date: April 11, 2002
    Applicant: Epicor, Inc.
    Inventors: John W. Sliwa, Matthias Vaska, Jonathan L. Podmore, Roxanne L. Richman, Scott C. Anderson, Gerard Champsaur, John E. Crowe
  • Publication number: 20020042610
    Abstract: An ablating device has a cover which holds an interface material such as a gel. The cover contains the interface material during initial placement of the device. The ablating device may also have a removable tip or a membrane filled with fluid. In still another aspect, the ablating device may be submerged in liquid during operation.
    Type: Application
    Filed: December 5, 2001
    Publication date: April 11, 2002
    Applicant: Epicor, Inc.
    Inventors: John W. Sliwa, Matthias Vaska, Jonathan L. Podmore, Roxanne L. Richman, Scott C. Anderson, Gerard Champsaur, John E. Crowe
  • Patent number: 6314962
    Abstract: The invention provides apparatus and methods for mapping conduction pathways and creating lesions in the heart wall for the treatment of atrial fibrillation. The apparatus may include at least one epicardial ablation probe having a plurality of electrodes for creating a lesion. The apparatus and method facilitate the formation of a lesion which electrically isolates the pulmonary veins from the surrounding myocardium.
    Type: Grant
    Filed: November 15, 1999
    Date of Patent: November 13, 2001
    Assignee: Epicor, Inc.
    Inventors: Matthias Vaska, Benjamin Pless, David A. Gallup, Jack E. Ulstad, Jr., Scott C. Anderson, Roxanne L. Richman
  • Patent number: 6314963
    Abstract: The invention provides apparatus and methods for mapping conduction pathways and creating lesions in the heart wall for the treatment of atrial fibrillation. The apparatus may include at least one epicardial ablation probe having a plurality of electrodes for creating a lesion. The apparatus and method facilitate the formation of a lesion which electrically isolates the pulmonary veins from the surrounding myocardium.
    Type: Grant
    Filed: November 15, 1999
    Date of Patent: November 13, 2001
    Assignee: Epicor, Inc.
    Inventors: Matthias Vaska, Banjamin Pless, David A. Gallup, Jack E. Ulstad, Jr., Scott C. Anderson, Roxanne L. Richman
  • Patent number: 6311692
    Abstract: The invention provides apparatus and methods for mapping conduction pathways and creating lesions in the heart wall for the treatment of atrial fibrillation. The apparatus may include at least one epicardial ablation probe having a plurality of electrodes for creating a lesion. The apparatus and method facilitate the formation of a lesion which electrically isolates the pulmonary veins from the surrounding myocardium.
    Type: Grant
    Filed: July 19, 1999
    Date of Patent: November 6, 2001
    Assignee: Epicor, Inc.
    Inventors: Matthias Vaska, Benjamin Pless, David A. Gallup, Jack E. Ulstad, Jr., Scott C. Anderson, Roxanne L. Richman
  • Patent number: 5562720
    Abstract: An endometrial ablation device and a method of manufacturing and using the device. An RF current is passed through an endometrium to heat it. An electroconductive expandable member such as a balloon is used as the medium for passing the current and causing the heating of the endometrium. The power delivered from a power source to the balloon is selectively provided to a plurality of electrode area segments on the balloon with each of the segments have a thermistor associated with it whereby temperature is monitored and controlled by a feedback arrangement from the thermistors. The selective application of power is provided on the basis of a switching arrangement which provides either monopolar or bipolar energy to the electrodes. The method of manufacturing the ablation device includes using commercially available stretchable sheet material or providing a mandrel or support base and coating the mandrel or base with an uncured emulsion. The emulsion is then cured to form a bladder-like coating.
    Type: Grant
    Filed: October 6, 1994
    Date of Patent: October 8, 1996
    Assignee: Vesta Medical, Inc.
    Inventors: Roger A. Stern, Vincent N. Sullivan, Roxanne L. Richman, Loren L. Roy, Robert L. Marion, Thomas D. Striegler